Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial-Reference-Cited by-同舟云学术

Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial

Published:2017-12-02 Issue:12 Volume:6 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Alfaddagh Abdulhamied¹,Elajami Tarec K.¹,Ashfaque Hasan¹,Saleh Mohamad¹,Bistrian Bruce R.¹,Welty Francine K.¹

Affiliation:

1. Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference51 articles.

1. Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges

2. Clinical Predictors of Plaque Progression Despite Very Low Levels of Low-Density Lipoprotein Cholesterol

3. Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome

4. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

5. Dual-energy computed tomography imaging to determine atherosclerotic plaque composition: A prospective study with tissue validation

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Eicosapentaenoic and Docosahexaenoic Acid Supplementation on Coronary Artery Calcium Progression in Subjects With Diabetes and Coronary Artery Disease: A Secondary Analysis of a Randomized Trial;The American Journal of Cardiology;2024-08

2. Advancements in risk stratification and management strategies in primary cardiovascular prevention;Atherosclerosis;2024-08

3. Higher epicardial adipose tissue volume is associated with higher coronary fatty plaque volume and is regulated by waist circumference but not EPA+DHA supplementation;Journal of Clinical Lipidology;2024-07

4. Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regression;American Journal of Preventive Cardiology;2024-06

5. Effects of niacin and omega-3 fatty acids on HDL-apolipoprotein A-I exchange in subjects with metabolic syndrome;PLOS ONE;2024-02-26